|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
109,470,000 |
Market
Cap: |
88.45(M) |
Last
Volume: |
627,989 |
Avg
Vol: |
622,110 |
52
Week Range: |
$0.5252 - $1.41 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 4.1 |
Insider 3/6 Months : 4.7 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxart is a clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology proprietary oral vaccine platform. Co.'s oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Co.'s investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. In addition, Co. is in early development of its first therapeutic vaccine targeting cervical cancer and dysplasia caused by human papillomavirus.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
20,000 |
20,000 |
40,000 |
Total Buy Value |
$0 |
$13,578 |
$13,578 |
$28,718 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fox James |
Director |
|
2015-06-09 |
4 |
B |
$1.99 |
$139,300 |
I/I |
70,000 |
100,614 |
2.1 |
- |
|
Fox James |
Director |
|
2015-05-12 |
4 |
A |
$2.20 |
$16,500 |
D/D |
7,500 |
7,500 |
|
- |
|
Patti Joseph M |
CEO |
|
2015-03-27 |
4 |
B |
$2.27 |
$45,689 |
D/D |
20,000 |
121,128 |
2.81 |
- |
|
Plumb Russell H |
Vice Chairmen |
|
2014-10-01 |
4 |
A |
$2.45 |
$98,000 |
D/D |
40,000 |
40,000 |
|
- |
|
Patti Joseph M |
EVP, Corporate Dev & Strategy |
|
2014-06-30 |
4 |
B |
$2.86 |
$28,600 |
D/D |
10,000 |
68,241 |
2.74 |
- |
|
Patti Joseph M |
EVP, Corporate Dev & Strategy |
|
2014-06-27 |
4 |
B |
$2.78 |
$14,026 |
D/D |
5,000 |
67,241 |
2.74 |
- |
|
Patti Joseph M |
EVP, Corporate Dev & Strategy |
|
2014-06-11 |
4 |
B |
$2.80 |
$16,172 |
D/D |
5,616 |
62,241 |
2.74 |
- |
|
Plumb Russell H |
CEO & President |
|
2014-06-11 |
4 |
B |
$2.79 |
$89,077 |
D/D |
29,331 |
127,579 |
2.81 |
- |
|
Patti Joseph M |
EVP, Corporate Dev & Strategy |
|
2014-06-10 |
4 |
B |
$2.45 |
$21,753 |
D/D |
8,851 |
56,625 |
2.74 |
- |
|
Plumb Russell H |
CEO & President |
|
2014-06-10 |
4 |
B |
$2.45 |
$6,615 |
D/D |
2,700 |
98,248 |
2.81 |
- |
|
185 Records found
|
|
Page 8 of 8 |
|
|